MNK

Mallinckrodt plc
7.55
0.08 (1.07%)
Upgrade to Real-Time
Afterhours (Closed)
7.55
Volume 25,019
Bid Price
Ask Price
News -
Day High 7.55

Low
7.31

52 Week Range

High
16.44

Day Low 7.33
Company Name Stock Ticker Symbol Market Type
Mallinckrodt plc MNK AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 1.07% 7.55 16:30:00
Open Price Low Price High Price Close Price Prev Close
7.38 7.33 7.55 7.55 7.47
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
314 25,019 $ 7.39 $ 184,873 - 7.31 - 16.44
Last Trade Time Type Quantity Stock Price Currency
20:00:00 100 $ 7.55 USD

Period:

Draw Mode:

Mallinckrodt plc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 99.44M 13.17M 11.14M $ 2.21B $ -994.18M -8.47 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 898.84k 12.10%

more financials information »

Mallinckrodt News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MNK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week7.527.987.317.5362,7710.030.4%
1 Month7.548.847.317.7564,0830.010.13%
3 Months12.9513.007.319.0180,293-5.40-41.7%
6 Months15.5916.447.319.3571,926-8.04-51.57%
1 Year15.5916.447.319.3571,926-8.04-51.57%
3 Years15.5916.447.319.3571,926-8.04-51.57%
5 Years15.5916.447.319.3571,926-8.04-51.57%

Mallinckrodt Description

Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which includes innovative specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of revenue from the United States.